Breadcrumb

CORE News

COVID-19 vaccination highly effective in individuals with immune-related inflammatory diseases

RI-MUHC researcher Sasha Bernatsky is senior author of a nationwide study

$6.7 million to study the impacts of COVID-19 on children

Health Minister Jean-Yves Duclos visits Montreal to announce a new investment in pediatric research and to congratulate researcher...

Nadine Kronfli receives 2021 AMMI Canada New Investigator Award

RI-MUHC researcher confronts the unique challenges of eliminating infectious diseases in prisons

Benefits of fluvoxamine confirmed in new study

Preventing hospitalization following COVID-19 infection in vulnerable populations

Michael S. Kramer awarded the Prix du chercheur émérite 2020-2021 by the RRSPQ

The RI-MUHC senior scientist will present a seminar on “Maternal and child population health...

TB and COVID-19, a joint battle?

On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.

Spotlight paper in World Journal of Hepatology: Alshaima Al Hinai

Recognition for former RI-MUHC trainee’s work on nonalcoholic fatty liver disease

Fall 2021 CIHR competition results

RI-MUHC teams received $9.5 million in project funding

A clear picture of the cost and efficacy of COVID-19 outpatient treatments

In a new study, RI-MUHC researchers have assessed all available outpatient therapies for COVID-19 to facilitate...

Explore news and events at the RI-MUHC